FDA recall D-0003-2021

Teva Pharmaceuticals USA · Class II · drug

Product

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.

Reason for recall

Failed Stability Specifications: Below specification result for buprenorphine release rate.

Distribution

Nationwide in the U.S. and PR

Key facts

Status
Terminated
Initiation date
2020-09-04
Report date
2020-10-07
Termination date
2021-08-26
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0003-2021